Results 1 to 10 of about 6,405 (201)

Furazolidone reduces the pathogenesis of Trueperella pyogenes and Pseudomonas aeruginosa co-infection in a mouse model [PDF]

open access: yesHeliyon
The prevalence of abscess disease significantly limits the population expansion of captive forest musk deer, which is an endangered species protected by the legislation of China.
Nan Yang   +11 more
doaj   +2 more sources

In Vitro Therapeutic Efficacy of Furazolidone for Antimicrobial Susceptibility Testing on Campylobacter [PDF]

open access: yesAntibiotics
Background: Campylobacter causes gastroenteritis worldwide with increasing antimicrobial resistance. Furazolidone (FZD) shows potential in resource-poor areas but needs further study.
Jeel Moya-Salazar   +6 more
doaj   +2 more sources

Efficacy and safety of tetracycline vs. amoxicillin in furazolidone-based rescue therapy for Helicobacter pylori: a real-world analysis [PDF]

open access: yesAnnals of Medicine
Background and aim Despite the increasing rates of antibiotic resistance, furazolidone-based regimens have demonstrated promise in Helicobacter pylori eradication. Therefore, this study aims to evaluate the comparative efficacy and safety of tetracycline
Jinliang Xie   +8 more
doaj   +2 more sources

Anti‐Helicobacter pylori Infection Treatment and Pulmonary Hypersensitivity: Case Series and Review of the Literature [PDF]

open access: yesThe Clinical Respiratory Journal
Background Helicobacter pylori (H. pylori) infection is currently widespread throughout the world. Bismuth‐containing quadruple therapy is widely used, but it has rarely been associated with interstitial lung disease.
Shan Xu   +3 more
doaj   +2 more sources

Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Acetyl Cysteine in Augmented Therapy [PDF]

open access: yesPharmaceutics
Helicobacter pylori (H. pylori) infection is a significant global health concern, affecting approximately 50% of the world’s population and leading to gastric ulcers, gastritis, and gastric cancer.
Muhammad Irfan Alam   +4 more
doaj   +2 more sources

Risk factors of furazolidone-associated fever.

open access: yesPLoS ONE, 2022
BackgroundFurazolidone is a synthetic nitrofuran with a broad spectrum of antimicrobial action and has been widely used in the treatment of Helicobacter pylori (H. pylori) infection. However, its safety profile has not been clarified.
Jiali Zhang   +6 more
doaj   +1 more source

Susceptibility-guided vs. empirical 10-day quadruple treatment for Helicobacter pylori-infected patients: A prospective clinical trial of first-line therapy

open access: yesFrontiers in Microbiology, 2022
BackgroundThe increasing antimicrobial resistance of Helicobacter pylori (H. pylori) has resulted in a fall in cure rates. We aimed to assess the effectiveness of first-line susceptibility-guided therapy and furazolidone-based quadruple therapy for H ...
Peiwei Li   +5 more
doaj   +1 more source

Safety of furazolidone-containing regimen in Helicobacter pylori infection: a systematic review and meta-analysis

open access: yesBMJ Open, 2020
Objectives Furazolidone containing regimen is effectivefor Helicobacter pylori (H. pylori) infection, but its safetyremains controversial. To assess the safety of furazolidone containing regimenin H.
Jing Liu   +6 more
doaj   +1 more source

Calreticulin-STAT3 signaling pathway modulates mitochondrial function in a rat model of furazolidone-induced dilated cardiomyopathy. [PDF]

open access: yesPLoS ONE, 2013
BACKGROUND: Calreticulin is a Ca(2+)-binding chaperone of the endoplasmic reticulum which regulates the signal transducer and activator of transcription 3 (STAT3). The effects of the calreticulin-STAT3 signaling pathway on cardiac mitochondria and on the
Ming Zhang   +7 more
doaj   +1 more source

DEVELOPMENT OF NITROFURAN DERIVATIVE: COMPOSITION AND TECHNOLOGY OF EFFERVESCENT TABLETS WITH SOLID DISPERSIONS

open access: yesФармация и фармакология (Пятигорск), 2022
Taking into account the current Product specification file, the aim of the work was to develop the composition and technology for obtaining effervescent tablets based on solid dispersions of furazolidone in the form of an aqueous solution for external ...
A. O. Elagina   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy